← Back
$LXEO All transactions

Lexeo Therapeutics, Inc.

A

$ Value

$0

Shares

10,890

Price

$0

Filed

Oct 17

Insider

Name

See Tai Sandi

Title

Chief Development Officer

CIK

0002009350

Roles

Officer

Transaction Details

Transaction Date

2025-10-15

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

69,750

Footnotes

Represents a sale to cover tax obligations on the release of Restricted Stock Units ("RSUs"). | This transaction was executed in multiple trades at prices ranging from $8.53 to $9.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | This transaction was executed in multiple trades at prices ranging from $9.53 to $9.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | Includes 49,138 RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Filing Info

Accession No.

0002009350-25-000003

Form Type

4

Issuer CIK

0001907108

See Tai Sandi's History

Date Ticker Type Value
2025-11-18 LXEO $4K
2025-10-17 LXEO $34K
2025-10-17 LXEO $421
2025-10-15 LXEO A $0
2025-08-18 LXEO $2K
2025-05-16 LXEO $1K

Other Insiders at LXEO (90d)

Insider Bought Sold Last
Townsend Richard Nolan
Chief Executive Officer
$313K 2026-04-06